From Yahoo Finance: 2024-05-21 01:30:00

Sanofi, Formation Bio, and OpenAI have announced a groundbreaking collaboration to develop AI-powered software to speed up drug development and introduce new medicines more efficiently. Each team will contribute expertise and resources to create custom solutions across the drug development process, marking a significant first within the pharma and life sciences industries. Sanofi aims to become a leading biopharma company fueled by AI at a large scale, leveraging this partnership to utilize proprietary data for AI model development. OpenAI will provide cutting-edge AI capabilities to fine-tune models, while Formation Bio brings in its tech-driven drug development platform to deploy AI technologies across all pharma lifecycle stages. This partnership seeks to revolutionize drug development in the industry and accelerate the pace of bringing new treatments to patients globally.



Read more at Yahoo Finance: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration